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sound to assess aortic stenosis and PET/computed tomography (CT) with 18F-
NaF to assess calciﬁcation severity. Thereafter, 8 animals were subsequently
treated with local delivery of a mixture containing 500 μg/l zoledronate that was
delivered on the cusps of the aortic valve, by a dedicated balloon catheter.A
placebo mixture was administered on the rest 8 animals (control group). At 28
days all animals underwent a follow-up cardiac imaging with PET-CT 18F-NaF.
The progression of calciﬁcation was assessed by calculating the difference in SU-
Vmax, SUVmean, TBRmax and TBR mean at baseline and at follow up both for
AV and ascending aorta (AA). After the second PET/CT examination all animals
were sacriﬁced and all aortic valves were collected and analyzed by histology.
Results: At baseline, all animals developed aortic valve stenosis with severe cal-
ciﬁcation. No differences regarding AVA were recorded between both groups.
(21.37±1.76 vs 21.98±3.12, p=0.53). In all animals the local delivery of zole-
dronate and placebo mixtures was successful and uncomplicated. A total of 48
cusps were histologically examined. The cusps treated with zoledronate had
signiﬁcantly lower expression of calcium content compared to the cusps of the
placebo group (16.40±0.90 vs 24.88±1.90% of the area, p<0.0001), whereas the
ascending aortas of both groups showed similar expression of calcium content
(23.58±4.43 vs 23.12±5.05% of the area, p=0.78). Regarding PET/CT analysis,
In the zolenodrate group, TBRmean and TBRmax at the level of AA showed a
signiﬁcant increase of calciﬁcation during follow up (1.31±0.11 versus 1.63±1.84,
p=0.001 and 1.42±0.11 versus 1.64±0.20, p=0.001). In the same group TBRmean
and TBRmax at the level of the AV did not show any signiﬁcant change in calciﬁca-
tion during the same period (1.20±0.12 versus 1.17±0.78, p=0.29 and 1.30±0.33
versus 1.40±0.67, p=0.08). Interestingly TBRmean showed a regression of calci-
ﬁcation at the level of AV compared to AA (-0.34±0.07 versus 0.30±0.11, p=0.01).
Conclusion: Inhibition of aortic valve calciﬁcation by local catheter-based deliv-
ery of zolendronic acid is feasible without evident short-term complications. The
potential clinical implications should be conﬁrmed in human studies
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Macrophage-derived osteopontin is fragmented by MMP-9 to hinder
angiogenesis in the post-myocardial infarction left ventricle
S. Holm Nielsen1, E.R. Flynn2, M. Lindsey2. 1Technical University of Den-
mark, Department of Biotechnology and Biomedicine, Lyngby, Denmark; 2The
University of Mississippi Medical Center, Jackson, United States of America
Background/Introduction: Extracellular matrix (ECM) turnover is a key event
during remodeling of the left ventricle (LV) following myocardial infarction (MI).
Turnover includes ECM degradation of existing ECM to remove necrotic myocytes
and synthesis to produce new ECM to form the infarct scar. Matrix metallopro-
teinases (MMPs) are elevated post-MI, and MMP-9 has a strong link to post-MI
LV dysfunction. The ECM protein osteopontin (OPN) increases post-MI, and we
previously identiﬁed by mass spectrometry a novel MMP-9 cleavage site of OPN
between amino acids 151 and 152. In vitro, peptides both upstream and down-
stream of the cleavage site increased cardiac ﬁbroblast migration without affecting
proliferation.
Purpose: The aim was to determine the biological function of the MMP-9 gener-
ated OPN fragments in vivo post-MI, using full length and cleavage-site speciﬁc
OPN antibodies.
Methods: C57/BL6J wild type (WT) and MMP-9 null mice (3–6 months old) were
used for coronary artery ligation and examined at days 0, 1, 3, 5, and 7 post-MI.
All animal procedures were approved by the Institutional Animal Care and Use
Committee at a University Medical Center in accordance with the Guide for the
Care and Use of Laboratory Animals. Immunoblotting and immunohistochemistry
were used to quantify full-length and OPN fragments. In vitro angiogenesis assay
was performed using HUVECs to compare spanning OPN fragment peptide to
fragment peptides upstream and downstream of the cleavage site.
Results: In vivo, both full length OPN and the cleaved OPN fragment increased
in the LV infarct in WT from days 1 to 5, with a peak elevation at day 5 post-MI.
Compared to WT, post-MI MMP-9 null LV showed a surprising increase in cleav-
age product, indicating that MMP-9 may further degrade OPN with prolonged
exposure. This was conﬁrmed by in vitro cleavage assay. By immunohistochem-
istry, we identiﬁed myocytes as the main cellular source of OPN in the absence of
MI. Post-MI, macrophages were robustly positive for both full length OPN and the
cleaved fragment. An angiogenesis assay was performed to further elucidate the
biological function of MMP-9 generated OPN fragments. While total tubular for-
mation was not altered, the OPN spanning peptide increased total branching and
segment length, effects that were abolished when peptides upstream or down-
stream of the cleavage site were used.
Conclusions: Our results demonstrated that in vivo post-MI, MMP-9 increased
OPN, which was proteolytically processed as a result of macrophage inﬁltration,
and in vitro cleavage peptides impaired angiogenesis quality.
Acknowledgement/Funding: NIH HL075360, HL129823, HL051971,
GM104357, GM114833, GM115428, GM103476, and GM103328 and VA
5I01BX000505
P1567 | BENCH
Mitochondrial calpains mediate SIRT3-dependent cardiac dysfunction
in LPS-induced endotoxemia
C. Koentges1, M.C. Cimolai1, K. Pfeil1, S. Alvarez2, M.M. Hoffmann3, C. Bode1,
H. Bugger1. 1University Heart Center Freiburg - Bad Krozingen, Freiburg,
Germany; 2University of Buenos Aires, Institute of Biochemistry and Molecular
Medicine, School of Pharmacy and Biochemistry, Buenos Aires, Argentina;
3University of Freiburg, Department of Clinical Chemistry, Freiburg University
Hospital, Freiburg, Germany
Sepsis may result in myocardial dysfunction, likely related to concomitant mito-
chondrial dysfunction in the heart. Sirtuin 3 (SIRT3) is a mitochondrial NAD+-
dependent deacetylase, lack of which impairs mitochondrial ATP synthesis by
decreased deacetylation of proteins of fatty acid oxidation, the TCA cycle and
electron transport chain. Since sepsis is characterized by hyperactivation of the
NAD+-dependent DNA repair enzyme poly(ADP-ribose)polymerase-1 (PARP1),
we hypothesized that myocardial NAD+ depletion due to myocardial PARP1 ac-
tivation may impair SIRT3 activity and thereby contribute to mitochondrial and
contractile dysfunction in sepsis. In isolated working hearts, 6 hours of LPS treat-
ment resulted in a decrease in cardiac power (-22%), palmitate oxidation (-33%)
and cardiac efﬁciency (-34%), accompanied by a 57% decrease of the myocardial
NAD+/NADH ratio compared to non-treated mice (all p<0.05). PARP1 deletion
lead to a complete recovery of cardiac function and NAD+ levels in LPS-treated
mice, which was completely blunted in LPS-treated PARP1−/−/SIRT3−/− double
knockout mice. Mitochondrial rates of ATP synthesis were decreased in LPS-
treated WT mice (-23%) and LPS-treated SIRT3−/− mice (-21%; all p<0.05). ATP
synthesis was completely normalized in LPS-treated PARP1−/− mice, but not in
LPS-treated PARP1−/−/SIRT3−/− mice. Since mitochondrial calpains cause mito-
chondrial dysfunction in sepsis by cleavage of ATP synthase, mice were treated
with the calpain inhibitor MDL-28170. MDL treatment resulted in a 81% improve-
ment of cardiac function in LPS-treated WT mice (p<0.05), but not in LPS-treated
SIRT3−/− mice. Thus, LPS-induced endotoxemia causes cardiac dysfunction by
PARP1-mediated NAD+ depletion and subsequent impairment in SIRT3 activity,
which may increase activation of mitochondrial calpains.
Acknowledgement/Funding: German Research Foundation
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Hydrogen gas inhalation improves survival in rats with lethal
haemorrhagic shock
T. Matsuoka1, M. Suzuki1, M. Sano2, K. Hayashida1, T. Tamura1, K. Homma1,
K. Fukuda2, J. Sasaki1. 1Keio University School of Medicine, Department of
Emergency and Critical Care Medicine, Tokyo, Japan; 2Keio University School of
Medicine, Department of Cardiology, Tokyo, Japan
Background: Haemorrhage is a major perioperative complication and is the pri-
mary cause of death following trauma among both civilians and military person-
nel. Whether patients can endure the state of shock due to haemorrhage until
deﬁnitive treatment is applied, affects their probability of survival. Hydrogen (H2)
gas has potential as an antioxidant. We investigated whether H2 gas inhalation
affects the tolerance to haemorrhagic shock and improves survival.
Methods: Thirty male Sprague-Dawley rats were anesthetised and subjected to
haemorrhagic shock by withdrawing blood until the mean arterial blood pressure
reached 30–35 mmHg. After 60 minutes of shock, rats were resuscitated with nor-
mal saline measuring four times the volume of shed blood over 15 minutes. The
rats were assigned to one of three groups: the early H2 group (the gas mixture
[1.3% H2, 26% O2, and 72.7% N2] was inhaled since the initiation of haemor-
rhagic shock, N=10), late H2 group (the gas mixture was inhaled since the initi-
ation of ﬂuid resuscitation, N=10), and control group (a control gas mixture [26%
O2 and 74% N2] was inhaled since the initiation of haemorrhagic shock, N=10).
Inhalation of the speciﬁed gas mixture continued for 2 hours after ﬂuid resusci-
tation. The survival rate at 6 hours after ﬂuid resuscitation and haemodynamic
parameters were evaluated.
Results: The survival rate was 30% in the control group, 80% in the early H2
group, and 50% in the late H2 group (P=0.036). The volume of blood removed to
induce shock tended to be the largest in the early H2 group (control vs. early H2
vs. late H2 groups: 2.42±0.12 vs. 2.76±0.11 vs. 2.44±0.11 mL/100 g; P=0.082).
Fluid resuscitation almost completely restored the blood pressure in the early H2
group, whereas it failed to fully restore the blood pressure in the late H2 and con-
Survival curve and changes in BP
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